NCT02593149View on ClinicalTrials.gov

Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap

NACompletedINTERVENTIONAL

Enrollment

1,902

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

End Stage Renal Disease (ESRD)

Interventions

DEVICE

ClearGuard HD End Cap

The ClearGuard HD end cap elutes chlorhexidine acetate into the hemodialysis hub

Trial Locations (1)

55404

DaVita Clinical Research, Minneapolis

Sponsors

Collaborators (1)

Davita Clinical Research

All Listed Sponsors

collaborator

Davita Clinical Research

INDUSTRY

lead

Pursuit Vascular, Inc.

INDUSTRY

NCT02593149 - Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap | Biotech Hunter | Biotech Hunter